StockWatch
·
Biotechnology: Pharmaceutical Preparations
BuybackJul 6, 2026, 07:02 AM

Novo Nordisk Repurchases 8.25M B Shares for DKK 2.42B

AI Summary

Novo Nordisk announced updates on its ongoing share repurchase program. Under the program initiated on May 6, 2026, the company has repurchased 8,250,000 B shares for a total of DKK 2,419,775,981. This includes 1,000,000 B shares bought between June 29 and July 3, 2026. Cumulatively, since February 4, 2026, Novo Nordisk has repurchased 23,009,179 B shares for DKK 6,219,775,971, as part of its DKK 15 billion program. The company now holds 0.9% of its share capital as treasury shares.

Key Highlights

  • Novo Nordisk repurchased 8,250,000 B shares under the program initiated May 6, 2026.
  • Total transaction value for this program reached DKK 2,419,775,981.
  • The company repurchased 1,000,000 B shares between June 29 and July 3, 2026.
  • Novo Nordisk now holds 40,194,480 B shares as treasury shares, representing 0.9% of share capital.
  • Overall share repurchase program aims for up to DKK 15 billion over 12 months from Feb 4, 2026.
  • Since Feb 4, 2026, 23,009,179 B shares have been repurchased for DKK 6,219,775,971.